A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer.
Publication
, Journal Article
Ballas, MS; Dennis, PA
Published in: Cancer Biol Ther
December 2005
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer Biol Ther
DOI
ISSN
1538-4047
Publication Date
December 2005
Volume
4
Issue
12
Start / End Page
1316 / 1317
Location
United States
Related Subject Headings
- Time Factors
- Survival Rate
- Platinum
- Paclitaxel
- Oncology & Carcinogenesis
- Neutropenia
- Maximum Tolerated Dose
- Lung Neoplasms
- Irinotecan
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Ballas, M. S., & Dennis, P. A. (2005). A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer. Cancer Biol Ther, 4(12), 1316–1317. https://doi.org/10.4161/cbt.4.12.2488
Ballas, Marc S., and Phillip A. Dennis. “A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer.” Cancer Biol Ther 4, no. 12 (December 2005): 1316–17. https://doi.org/10.4161/cbt.4.12.2488.
Ballas MS, Dennis PA. A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer. Cancer Biol Ther. 2005 Dec;4(12):1316–7.
Ballas, Marc S., and Phillip A. Dennis. “A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer.” Cancer Biol Ther, vol. 4, no. 12, Dec. 2005, pp. 1316–17. Pubmed, doi:10.4161/cbt.4.12.2488.
Ballas MS, Dennis PA. A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer. Cancer Biol Ther. 2005 Dec;4(12):1316–1317.
Published In
Cancer Biol Ther
DOI
ISSN
1538-4047
Publication Date
December 2005
Volume
4
Issue
12
Start / End Page
1316 / 1317
Location
United States
Related Subject Headings
- Time Factors
- Survival Rate
- Platinum
- Paclitaxel
- Oncology & Carcinogenesis
- Neutropenia
- Maximum Tolerated Dose
- Lung Neoplasms
- Irinotecan
- Humans